Follow
James Douketis
James Douketis
Prof of Medicine, David Braley Nancy Gordon Chair in Thromboembolic Disease, McMaster University
Verified email at mcmaster.ca
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
33034*2012
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
29468*2016
Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
JD Douketis, AC Spyropoulos, FA Spencer, M Mayr, AK Jaffer, ...
Chest 141 (2), e326S-e350S, 2012
3024*2012
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]
DCW Lau, JD Douketis, KM Morrison, IM Hramiak, AM Sharma, E Ur
Cmaj 176 (8), S1-S13, 2007
16452007
Systematic overview of warfarin and its drug and food interactions
AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ...
Archives of internal medicine 165 (10), 1095-1106, 2005
15302005
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ...
New England Journal of Medicine 340 (12), 901-907, 1999
14911999
Perioperative bridging anticoagulation in patients with atrial fibrillation
JD Douketis, AC Spyropoulos, S Kaatz, RC Becker, JA Caprini, AS Dunn, ...
New England Journal of Medicine 373 (9), 823-833, 2015
12572015
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
12222008
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
MA Crowther, JS Ginsberg, J Julian, J Denburg, J Hirsh, J Douketis, ...
New England Journal of Medicine 349 (12), 1133-1138, 2003
10942003
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis
LA Linkins, PT Choi, JD Douketis
Annals of internal medicine 139 (11), 893-900, 2003
9942003
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes
Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION ...
Anesthesiology 120 (3), 564-578, 2014
9212014
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice
JD Douketis, C Macie, L Thabane, DF Williamson
International journal of obesity 29 (10), 1153-1167, 2005
9102005
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
JD Douketis, C Kearon, S Bates, EK Duku, JS Ginsberg
Jama 279 (6), 458-462, 1998
8481998
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
Columbus Investigators
New England Journal of Medicine 337 (10), 657-662, 1997
7661997
Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with …
AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ...
Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020
7602020
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding …
LR Dolovich, JS Ginsberg, JD Douketis, AM Holbrook, G Cheah
Archives of internal medicine 160 (2), 181-188, 2000
6972000
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY …
JS Healey, J Eikelboom, J Douketis, L Wallentin, J Oldgren, S Yang, ...
Circulation 126 (3), 343-348, 2012
6932012
Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients
F Dentali, JD Douketis, M Gianni, W Lim, MA Crowther
Annals of internal medicine 146 (4), 278-288, 2007
6802007
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials
JW Eikelboom, DJ Quinlan, JD Douketis
The Lancet 358 (9275), 9-15, 2001
6752001
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates
D Siegal, J Yudin, S Kaatz, JD Douketis, W Lim, AC Spyropoulos
Circulation 126 (13), 1630-1639, 2012
5392012
The system can't perform the operation now. Try again later.
Articles 1–20